Serum interleukin-6, cardiovascular disease, and mortality in chronic lymphocytic leukemia. Background: Secondary AML (sAML) is a well recognized poor prognostic factor in AML. sAML is a heterogeneous ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results